Dabomb Protein Biotech (ROCO:6578) Change In Payables And Accrued Expense : NT$0.0 Mil (TTM As of Mar. 2025)

View and export this data going back to 2016. Start your Free Trial

What is Dabomb Protein Biotech Change In Payables And Accrued Expense?

Dabomb Protein Biotech's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2025 was NT$0.0 Mil. It means Dabomb Protein Biotech's Accounts Payable & Accrued Expense stayed the same from Dec. 2024 to Mar. 2025 .

Dabomb Protein Biotech's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2024 was NT$0.0 Mil. It means Dabomb Protein Biotech's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Dec. 2024 .

Dabomb Protein Biotech Change In Payables And Accrued Expense Historical Data

The historical data trend for Dabomb Protein Biotech's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Dabomb Protein Biotech Change In Payables And Accrued Expense Chart

Dabomb Protein Biotech Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Dabomb Protein Biotech Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Dabomb Protein Biotech Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

Dabomb Protein Biotech Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Dabomb Protein Biotech's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Dabomb Protein Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Dabomb Protein Biotech Corp (ROCO:6578) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

52,Gungye 3rd Road, Annan District, Tainan, TWN, 709

Website

https://www.dabombprotein.com

Dabomb Protein Biotech Corp is engaged in the manufacture, wholesale, and sale of hydrolyzed soy protein. Its products include Plant protein, Antibiotics alternatives, Pet care, Core technology, and CDMO(ODM/OEM). It operates in a single segment engaged in the manufacture, wholesale and sales of hydrolysed soy protein. Geographically it operates in Malaysia, Taiwan, USA, China, Vietnam, and Others with majority of the revenue deriving from Vietnam.

Dabomb Protein Biotech Headlines

No Headlines